They stand out as the only NASDAQ-listed company selected and approved by the U.S drug enforcement administration (DEA) for cultivation and sale of medical cannabis and cannabis-related products to pharmaceutical companies and research institutions in the U.S and globally.
The only NASDAQ listed company with U.S. federal authorization for cultivation of medical cannabis and API for Schedule 1 drugs
✓ Full support from the New Mexico State government
✓ Qualified for federal grants for cannabis research
✓ Qualified for API government purchase contracts
✓ Eligible for full banking services, insurance coverage, tax deductions
Key differentiating factors of bright Green's EB-5 Program
Combining its extensive expertise and experience in Asian Investor Reporting with its Fintech enabled solutions from ACPG’s portfolio company, Aleta Planet, ACPG will facilitate applicants through their U.S. green card application process from start to finish.
Copyright © 2025 ACPG Capital - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.